JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Neurology, Neurosurgery, and Psychiatry 2005;76:1164-1166; doi:10.1136/jnnp.2004.052126
Copyright © 2005 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Read responses to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramirez-Bermudez, J
Right arrow Articles by Corona, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramirez-Bermudez, J
Right arrow Articles by Corona, T
Related Collections
Right arrow Other Infectious Diseases
Right arrow Dementia

SHORT REPORT

Is dementia reversible in patients with neurocysticercosis?

J Ramirez-Bermudez1, J Higuera2, A L Sosa1, E Lopez-Meza3, M Lopez-Gomez3, T Corona3

1 Department of Neuropsychiatry, National Institute of Neurology and Neurosurgery, Mexico City, Mexico
2 Department of Neuroimaging, National Institute of Neurology and Neurosurgery, Mexico City, Mexico
3 Department of Neurology, National Institute of Neurology and Neurosurgery, Mexico City, Mexico

Correspondence to:
Correspondence to:
Dr T Corona
Department of Neurology, Instituto Nacional de Neurología y Neurocirugía. Insurgentes Sur 3877, La Fama 14269, México City, México; coronav{at}servidor.unam.mx


ABSTRACT
Objective: To determine the correlates and outcome of dementia in patients with neurocysticercosis (NCC).

Methods: Ninety consecutive patients with untreated NCC underwent a cognitive assessment (Mini-mental State Examination, Neurobehavioral Cognitive Status Examination, and IQCODE) and were classified as having or not having dementia according to DSM-IV criteria. Imaging and cerebrospinal fluid examination data were recorded. The cognitive measures were repeated six months after treatment with albendazole and steroids.

Results: At the initial evaluation 15.5% (n = 14) of the patients were classified as having dementia. Dementia was associated with older age, lower education level, increased number of parasitic lesions in the brain (mostly in the frontal, temporal, and parietal lobes). After six months, 21.5% of the patients from the dementia group continued to have a full dementia disorder and 78.5% no longer fulfilled the DSM-IV criteria for dementia, although some of these patients still showed mild cognitive decline.

Conclusions: The results of this study suggest that dementia occurs frequently in patients with untreated NCC, and it is reversible in most cases.


Abbreviations: COGNISTAT, Neurobehavioral Cognitive Status Examination; DRS, Delirium Rating Scale; IQCODE, Informant Questionnaire on Cognitive Decline; MMSE, Mini-mental State Examination; NCC, neurocysticercosis

Keywords: dementia; neurocysticercosis; neuropsychiatry




eLetters:

Read all eLetters

Dementia in Neurocysticercosis
Daniel Ciampi de Andrade, et al.
JNNP Online, 10 Nov 2005 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd.